
Tc-99m Sestamibi Scintimammography in the Evaluation of Response of Breast Carcinoma to Chemotherapy
1997; Lippincott Williams & Wilkins; Volume: 22; Issue: 9 Linguagem: Inglês
10.1097/00003072-199709000-00015
ISSN1536-0229
AutoresAndreiF Joaquim, Alberto Jorge Fernandez y Sagarra, Celso Darío Ramos, Renata de Almeida Coudry, Regina Aparecida Martinho Sagarra, Edwaldo E. Camargo,
Tópico(s)HER2/EGFR in Cancer Research
ResumoA 44-year-old premenopausal woman had a T3N0M0 breast cancer in the inner superior quadrant of the left breast. Her biopsy revealed a histologic grade III and nuclear grade II invasive ductal carcinoma with foci of comedocarcinoma. The patient was placed on three cycles of neoadjuvant chemotherapy with cyclophosphamide, epirubicin, and fluorouracil (FEC). Scintimammography, mammography, and histopathologic evaluation were obtained prior to and after treatment to evaluate the tumor response to chemotherapy. After modified radical mastectomy, histopathology demonstrated only 10% of viable tumor cells, 80% of collagenization, and 10% of tumor necrosis.
Referência(s)